Try our beta test site
1 study found for:    23268517 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B
Interventions: Other: Regression of fibrosis;   Other: Specific risk factors related to hepatocellular carcinoma

Study has passed its completion date and status has not been verified in more than two years.